Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q2 2018 (← Previous) (Next →)
Filing Date: Aug 14, 2018
Total Value: $1.025B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CHEMOCENTRYX INC | 7,034,346 | $92.64M | 9.0% | — | — | COM | 16383L106 |
| — | MERUS N V | 3,914,913 | $89.1M | 8.7% | — | — | COM | N5749R100 |
| — | ARRAY BIOPHARMA INC | 4,672,195 | $78.4M | 7.7% | — | — | COM | 04269X105 |
| CYTK | CYTOKINETICS INC | 5,550,890 | $46.07M | 4.5% | — | — | COM NEW | 23282W605 |
| — | ARQULE INC | 7,447,912 | $41.19M | 4.0% | — | — | COM | 04269E107 |
| — | BLUEPRINT MEDICINES CORP | 646,811 | $41.06M | 4.0% | — | — | COM | 09627Y109 |
| KURA | KURA ONCOLOGY INC | 2,057,346 | $37.44M | 3.7% | — | — | COM | 50127T109 |
| — | MIRATI THERAPEUTICS INC | 745,000 | $36.73M | 3.6% | — | — | COM | 60468T105 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $34.51M | 3.4% | — | — | COM NEW | 12648L601 |
| XNCR | XENCOR INC | 869,645 | $32.19M | 3.1% | — | — | COM | 98401F105 |
| XOMA | XOMA CORP DEL | 1,502,800 | $31.38M | 3.1% | — | — | COM NEW | 98419J206 |
| — | CONCERT PHARMACEUTICALS INC | 1,817,138 | $30.58M | 3.0% | — | — | COM | 206022105 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 15,232,268 | $29.09M | 2.8% | — | — | COM | 45665G303 |
| — | PIERIS PHARMACEUTICALS INC | 5,346,838 | $27.11M | 2.6% | — | — | COM | 720795103 |
| ANAB | ANAPTYSBIO INC | 335,265 | $23.82M | 2.3% | — | — | COM | 032724106 |
| IONS | IONIS PHARMACEUTICALS INC | 570,000 | $23.75M | 2.3% | — | — | COM | 462222100 |
| — | BIOLINERX LTD | 25,995,575 | $23.52M | 2.3% | — | — | SPONSORED ADR | 09071M106 |
| — | FORWARD PHARMA A/S | 8,503,425 | $23.13M | 2.3% | — | — | SPONSORED ADR | 34986J105 |
| — | GALMED PHARMACEUTICALS LTD | 1,761,567 | $20.96M | 2.0% | — | — | SHS | M47238106 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,890,507 | $20.76M | 2.0% | — | — | COM | 221015100 |
| — | IMMUNE DESIGN CORP | 4,158,353 | $18.92M | 1.8% | — | — | COM | 45252L103 |
| — | FIVE PRIME THERAPEUTICS INC | 1,129,761 | $17.86M | 1.7% | — | — | COM | 33830X104 |
| — | VERASTEM INC | 2,242,353 | $15.43M | 1.5% | — | — | COM | 92337C104 |
| SPRO | SPERO THERAPEUTICS INC | 1,048,958 | $15.39M | 1.5% | — | — | COM | 84833T103 |
| — | MEI PHARMA INC | 3,080,308 | $12.14M | 1.2% | — | — | COM NEW | 55279B202 |
| RCUS | ARCUS BIOSCIENCES INC | 959,840 | $11.75M | 1.1% | — | — | COM | 03969F109 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 606,715 | $11.6M | 1.1% | — | — | COM CL A | 46333X108 |
| — | CIDARA THERAPEUTICS INC | 1,930,670 | $10.04M | 1.0% | — | — | COM | 171757107 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,417,967 | $9.529M | 0.9% | — | — | COM | 74366E102 |
| — | ONCOMED PHARMACEUTICALS INC | 4,099,589 | $9.47M | 0.9% | — | — | COM | 68234X102 |
| — | SPRING BK PHARMACEUTICALS INC | 785,950 | $9.314M | 0.9% | — | — | COM | 849431101 |
| — | REGULUS THERAPEUTICS INC | 13,685,204 | $9.021M | 0.9% | — | — | COM | 75915K101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,233,618 | $8.66M | 0.8% | — | — | COM | 87164F105 |
| — | VBI VACCINES INC | 3,100,000 | $8.525M | 0.8% | — | — | COM NEW | 91822J103 |
| — | ALBIREO PHARMA INC | 220,000 | $7.81M | 0.8% | — | — | COM | 01345P106 |
| — | CONTRAFECT CORP | 3,361,071 | $7.428M | 0.7% | — | — | COM | 212326102 |
| — | ERYTECH PHARMA | 625,000 | $7.213M | 0.7% | — | — | SPONSORED ADR | 29604W108 |
| XENE | XENON PHARMACEUTICALS INC | 720,830 | $6.632M | 0.6% | — | — | COM | 98420N105 |
| — | GTX INC DEL | 386,134 | $5.912M | 0.6% | — | — | COM NEW | 40052B207 |
| — | SURFACE ONCOLOGY INC | 334,333 | $5.453M | 0.5% | — | — | COM | 86877M209 |
| — | MERRIMACK PHARMACEUTICALS INC | 1,110,588 | $5.453M | 0.5% | — | — | COM NEW | 590328209 |
| — | ALPINE IMMUNE SCIENCES INC | 643,059 | $4.868M | 0.5% | — | — | COM | 02083G100 |
| — | GENOCEA BIOSCIENCES INC | 5,265,000 | $4.505M | 0.4% | — | — | COM | 372427104 |
| — | TOCAGEN INC | 471,007 | $4.399M | 0.4% | — | — | COM | 888846102 |
| — | MOLECULAR TEMPLATES INC | 688,629 | $3.602M | 0.4% | — | — | COM | 608550109 |
| — | SUNESIS PHARMACEUTICALS INC | 1,684,636 | $3.571M | 0.3% | — | — | COM PAR | 867328700 |
| — | ESSA PHARMA INC | 552,791 | $2.09M | 0.2% | — | — | COM NEW | 29668H708 |
| — | ADURO BIOTECH INC | 295,965 | $2.072M | 0.2% | — | — | COM | 00739L101 |
| — | VICAL INC | 1,332,605 | $1.532M | 0.1% | — | — | COM NEW | 925602203 |
| — | LOXO ONCOLOGY INC | 4,089 | $709K | 0.1% | — | — | COM | 548862101 |
| — | ZYMEWORKS INC | 19,804 | $293K | 0.0% | — | — | COM | 98985W102 |